Your World of Legal Intelligence
 United Kingdom | +44 (0) 20 7284 8080

Zealand Pharma announces grant of new warrants to SVP under employee warrant programme.

Document Cited in Related
Vincent

NORDIC BUSINESS REPORT-October 16, 2018-Zealand Pharma announces grant of new warrants to SVP under employee warrant programme

(C)2018 M2 COMMUNICATIONS http://www.m2.com

Zealand Pharma A/S (Zealand) (CPH:ZEAl) (NYSE:ZEAL), a biotechnology company focused on the discovery and development of peptide-based medicines, announced on Monday that it has granted warrants to the company's SVP of Corporate and Business Development, Marino Garcia.

These warrants are granted under the warrant programme covered by the authority pursuant to section 8.4 of Zealand's Articles of Association, adopted at Zealand's General Meeting on 21 April 2015.

Reportedly, this warrant programme is an incentive scheme reflecting Zealand's objective to attract and retain first-rate employees and help ensure shared short- and long-term interests for the management, employees and shareholders of the company.

Under this grant, a total of 40,000 warrants have been granted, giving the rights to subscribe for up to 40,000 new Zealand shares with a nominal value of DKK1.00 each, corresponding to 0.13% of the company's total outstanding share capital. The exercise price is DKK90.00, calculated as the closing...

To continue reading

Request your trial
COPYRIGHT Normans Media Ltd.

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT